| Tap a line for its trend | Currentlast close | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 0.9 | 0.9 | 1.8 | 1.7 | 1.3 | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 148 | 148 | 151 | 127 | 205 | ||
| — | −2.4% | +19.2% | −38.1% | — | ||
| 12.3 | 12.3 | 23.0 | 5.2 | 22.1 | ||
| 8.3% | 8.3% | 15.2% | 4.1% | 10.8% | ||
| 8.4 | 8.4 | 19.4 | 2.4 | 19.2 | ||
| −6.2 | −6.2 | 5.9 | 17.5 | 35.7 | ||
| −3.5 | −3.5 | −8.3 | −9.1 | −20.8 | ||
| −9.7 | −9.7 | −2.4 | 8.4 | 14.9 | ||
From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.
In ₹ Crore except Per Share 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Current last close | |
|---|---|---|---|---|---|---|
| - Cash, Equiv & ST Investments | 1.3 | 1.7 | 1.8 | 0.9 | 0.9 | |
| Revenue | 205.4 | 127.1 | 151.5 | 147.8 | 147.8 | |
| Growth %, YoY | — | -38.1 | +19.2 | -2.4 | — | |
| EBITDA | 22.1 | 5.2 | 23.0 | 12.3 | 12.3 | |
| Margin % | 10.77 | 4.10 | 15.17 | 8.33 | 8.33 | |
| EBIT | 19.2 | 2.4 | 19.4 | 8.4 | 8.4 | |
| Cash from Operations | 35.7 | 17.5 | 5.9 | -6.2 | -6.2 | |
| Capital Expenditures | -20.8 | -9.1 | -8.3 | -3.5 | -3.5 | |
| Free Cash Flow | 14.9 | 8.4 | -2.4 | -9.7 | -9.7 | |
Figures from the company's filings with NSE
Kanchi Karpooram (NSE: KANCHI) — financials from its filings with NSE.
Kanchi Karpooram's basic earnings per share (EPS) were ₹11.88 in FY26.
In 2026, Kanchi Karpooram has declared one dividend: ₹1 with record date 15 September 2026.
In FY26, Kanchi Karpooram generated ₹6.2 crore of cash from operations and spent ₹3.5 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of −₹9.7 crore. In FY25 it was −₹2.4 crore.
On FY26 consolidated figures, against Amal and Chemcrux Enterprises: Kanchi Karpooram's operating margin of 5.7% is the lowest of the three (Amal 7.5%, Chemcrux Enterprises 6.6%; peer average 7.0%); its revenue growth over three years of −10.4% a year is the lowest of the three (Amal 29.4% a year, Chemcrux Enterprises −4.6% a year; peer average 12.4% a year).
From Kanchi Karpooram's own consolidated results, balance sheets and shareholding patterns filed with NSE. Ratios are calculated by Alphave from those filings as each answer describes.
Consolidated figures from the company's filings with NSE; prices are NSE closing prices.